Stockscreener 앱 받기
2.57
3.75%
-0.10
전일 마감가:
$2.67
열려 있는:
$2.68
하루 거래량:
64,029
Relative Volume:
1.17
시가총액:
$24.78M
수익:
$328.80K
순이익/손실:
$-10.44M
주가수익비율:
-1.9171
EPS:
-1.3406
순현금흐름:
$-7.72M
1주 성능:
-26.78%
1개월 성능:
-33.59%
6개월 성능:
-50.00%
1년 성능:
+4.47%
1일 변동 폭
$2.52
$2.7656
1주일 범위
$2.52
$3.56
52주 변동 폭
$0.72
$20.32
에데사 바이오테크 Stock (EDSA) Company Profile
명칭
Edesa Biotech Inc
전화
(905) 475-1234
주소
100 SPY COURT, MARKHAM, ON
Compare EDSA vs VRTX, MRNA, REGN, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EDSA
Edesa Biotech Inc
|
2.57 | 24.78M | 328.80K | -10.44M | -7.72M | -1.3406 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
에데사 바이오테크 주식(EDSA)의 최신 뉴스
Edesa Biotech completes US$3.5 million private placement - fasken.com
Edesa Biotech Stock Price Forecast. Should You Buy EDSA? - StockInvest.us
Stonepine Capital Management, LLC Expands Edesa Biotech Inc (EDS - GuruFocus
Insider share moves at Edesa Biotech (EDSA) detailed in new SEC filing - Stock Titan
Velan Capital Investment Management LP Expands Edesa Biotech Inc (EDSA) Stake - GuruFocus
Edesa Biotech (EDSA) Dips 3.5% as Shares Test Key Support ZoneDay Trade Opportunities - dars.gov.et
EDSA Q2 2026 Earnings: Wider-than-Expected Loss Reflects Continued Clinical-Stage InvestmentEPS Revision Trend - vinanet.vn
Stonepine group discloses sub-10% Edesa Biotech (NASDAQ: EDSA) position - Stock Titan
Velan Capital lifts Edesa Biotech (EDSA) stake to 9.99% with warrant leverage - Stock Titan
Edesa Biotech (NASDAQ: EDSA) major holder's multi-million-share stake detailed - stocktitan.net
EDSA: Recruitment in Phase 2 Vitiligo Study Set to Get Underway - finance.yahoo.com
Edesa Biotech completes US$25 million public offering - fasken.com
Edesa (EDSA) Results Review: The Bottom-Line Figure Trails Its Comparison at the Close; Price Reaction: Shares Close 17.22% Lower in Latest TradingInterim Report - vinanet.vn
Edesa Biotech Enters Underwriting Deal With Guggenheim for $23.1M Equity Offering - TradingView
Edesa Biotech Prices $25 Million Stock-and-Warrant Offering to Fund Drug Pipeline - finance.biggo.com
Edesa Biotech Shares Tumble 13% on $25 Million Equity Offering - finance.biggo.com
Edesa (EDSA) Quarter in Focus: EPS Does Not Reach the Reported Estimate for the Current Session; Share Move - vinanet.vn
Edesa Biotech Stock Sinks After Fresh Capital Raise - TradingView
Edesa Biotech raises USD 25m to fuel vitiligo Phase II - AllSci
Edesa Biotech Stock Sinks After Fresh Capital Raise - Yahoo Finance
Edesa (EDSA) Results Review: The Bottom-Line Figure Trails Its Comparison at the Close; Price Reaction: Shares Close 17.22% Lower in Latest TradingEstimate Revision Count - careplusvn.com
Edesa (EDSA) Results Review: The Bottom-Line Figure Trails Its Comparison at the Close; Price Reaction: Shares Close 17.22% Lower in Latest TradingQuarterly Profit Report - dars.gov.et
Edesa (EDSA) Quarter in Focus: EPS Does Not Reach the Reported Estimate for the Current Session; Share Move - careplusvn.com
Edesa (EDSA) Results Review: The Bottom-Line Figure Trails Its Comparison at the Close; Price Reaction: Shares Close 17.22% Lower in Latest TradingReturn On Assets - dars.gov.et
Edesa (EDSA) Results Review: The Bottom-Line Figure Trails Its Comparison at the Close; Price Reaction: Shares Close 17.22% Lower in Latest TradingFree Cash Flow Trends - dars.gov.et
Edesa (EDSA) Results Review: The Bottom-Line Figure Trails Its Comparison at the Close; Price Reaction: Shares Close 17.22% Lower in Latest TradingProfit Guidance Range - dars.gov.et
Edesa Biotech Raises $25 Million in Public Offering to Advance Immuno-Inflammatory Pipeline - TipRanks
Edesa Biotech prices $25M public offering at $5.50 per share By Investing.com - Investing.com Australia
Edesa Biotech prices $25M public offering at $5.50 per share - Investing.com Australia
Edesa Biotech prices $25M public offering at $5.50 per share - Investing.com Nigeria
Edesa Biotech prices $25M public offering at $5.50 per share - Investing.com South Africa
Edesa Biotech prices $25M public offering at $5.50 per share - Investing.com
Edesa Biotech prices $25M public offering at $5.50 per share - Investing.com Canada
Edesa Biotech Announces Pricing of $25.0 Million Public Offering - Yahoo Finance
Edesa Biotech stock tumbles on public offering launch By Investing.com - Investing.com Canada
Edesa Biotech Launches Public Offering of Common Shares, Warrants - marketscreener.com
Edesa Biotech Launches Public Offering to Fund Immuno-Inflammatory Pipeline - tipranks.com
Edesa Biotech stock tumbles on public offering launch By Investing.com - Investing.com South Africa
Edesa Biotech stock tumbles on public offering launch By Investing.com - Investing.com Nigeria
Edesa Biotech launches public offering of common shares - Investing.com
Edesa Biotech stock tumbles on public offering launch By Investing.com - Investing.com South Africa
Edesa Biotech stock tumbles on public offering launch By Investing.com - Investing.com Australia
Edesa Biotech launches public offering of common shares By Investing.com - Investing.com India
Edesa Biotech stock tumbles on public offering launch - Investing.com
Edesa Biotech stock tumbles on public offering launch By Investing.com - Investing.com UK
Edesa Biotech Announces Proposed Public Offering of Common Shares and Warrants - Quiver Quantitative
Edesa Biotech Announces Proposed Public Offering - The Manila Times
Edesa Biotech Announces Proposed Public Offering - Yahoo Finance
Edesa Biotech(EDSA) Stock Options Chain | Quotes & News - Moomoo
Edesa Biotech Announces Proposed Public Offering - GlobeNewswire
에데사 바이오테크 (EDSA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
에데사 바이오테크 주식 (EDSA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Nijhawan Pardeep | Chief Executive Officer |
Mar 10 '26 |
Buy |
6.60 |
1,000 |
6,599 |
628,813 |
| Nijhawan Pardeep | Chief Executive Officer |
Mar 05 '26 |
Buy |
3.90 |
10,000 |
39,000 |
402,702 |
| Nijhawan Pardeep | Chief Executive Officer |
Mar 04 '26 |
Buy |
4.26 |
10,000 |
42,560 |
392,702 |
| Nijhawan Pardeep | Chief Executive Officer |
Mar 03 '26 |
Buy |
3.63 |
10,000 |
36,300 |
382,702 |
| Nijhawan Pardeep | Chief Executive Officer |
Mar 02 '26 |
Buy |
2.00 |
2,000 |
4,000 |
627,813 |
| Nijhawan Pardeep | Chief Executive Officer |
Mar 02 '26 |
Buy |
2.28 |
1,000 |
2,280 |
372,702 |
| Nijhawan Pardeep | Chief Executive Officer |
Feb 27 '26 |
Buy |
2.22 |
30,000 |
66,696 |
371,702 |
| Nijhawan Pardeep | Chief Executive Officer |
Feb 26 '26 |
Buy |
1.58 |
20,571 |
32,480 |
615,797 |
4.22%
자본화:
|
볼륨(24시간):